Standardize for Success with Mark Sawicki for The Medicine Maker

Dr. Mark Sawicki, Cryoport System’s CEO, shared his expertise on the future of regenerative medicine and the top challenges facing the industry today with The Medicine Maker. The article, “Standardize for Success,” contained his insight into the importance of standardization within the collection, processing, storage, and distribution of cellular therapies to support the expected growth of the regenerative medicine industry within the coming years.

“In my view, regardless of regulatory status for the collection and processing of ATMP starting materials, it is critical that the industry initiates efforts to standardize the activities associated with processes,” stated Sawicki. “Any standardized solution must address product consistency (regardless of geographic location), and also accommodate and provide efficiencies and scalability to the industry as a whole.”

Read the full article for more of Sawicki’s thoughts on the challenges facing the industry as well as his ideas on how to combat those challenges with information based on internal Cryoport data.